Come up with a name for your new list and we'll add to it:
Biolex Therapeutics raised a round of funding on August 22, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…